Cidara Therapeutics logo

Cidara Therapeutics Share Price Today (NASDAQ: CDTX)

Cidara Therapeutics share price is $50.55 & ₹4,335.04 as on 9 Jul 2025, 01.30 'hrs' IST

$50.55

2.25

(4.66%)

Market is closed - opens 7 PM, 09 Jul 2025

View live Cidara Therapeutics share price in Dollar and Rupees. Guide to invest in Cidara Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cidara Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Cidara Therapeutics share price movements

  • Today's Low: $46.01
    Today's High: $50.59

    Day's Volatility :9.05%

  • 52 Weeks Low: $10.14
    52 Weeks High: $56.83

    52 Weeks Volatility :82.16%

Cidara Therapeutics (CDTX) Returns

PeriodCidara Therapeutics IncIndex (Russel 2000)
3 Months
189.12%
0.0%
6 Months
103.01%
0.0%
1 Year
338.26%
0.0%
3 Years
243.33%
0.0%

Cidara Therapeutics (CDTX) Key Statistics

in dollars & INR

Previous Close
$48.3
Open
$47.99
Today's High
$50.59
Today's Low
$46.01
Market Capitalization
$1.0B
Today's Volume
$1.0M
52 Week High
$56.8288
52 Week Low
$10.14
Revenue TTM
$302.0K
EBITDA
$-107.8M
Earnings Per Share (EPS)
$-26.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-299.58%

How to invest in Cidara Therapeutics Stock (CDTX) from India?

It is very easy for Indian residents to invest directly in Cidara Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cidara Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cidara Therapeutics or CDTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cidara Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cidara Therapeutics shares which would translate to 0.017 fractional shares of Cidara Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Cidara Therapeutics, in just a few clicks!

Returns in Cidara Therapeutics (CDTX) for Indian investors in Rupees

The Cidara Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cidara Therapeutics investment value today

Current value as on today

₹4,41,160

Returns

₹3,41,160

(+341.16%)

Returns from Cidara Therapeutics Stock

₹3,38,422 (+338.42%)

Dollar Returns*

₹2,738 (+2.74%)

Indian investors sentiment towards Cidara Therapeutics (CDTX)

1175%

Period: Jun 8, 2025 to Jul 8, 2025. Change in 30 Days versus previous period

Search interest for Cidara Therapeutics Stock from India on INDmoney has increased by 1175% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cidara Therapeutics

  • RA Capital Management, LLC

    8.43%

  • VR Adviser, LLC

    8.11%

  • TCG Crossover Management, LLC

    7.76%

  • Adage Capital Partners Gp LLC

    7.63%

  • Bvf Inc

    7.13%

  • Bain Capital Life Sciences Investors, LLC

    5.42%

Analyst Recommendation on Cidara Therapeutics

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cidara Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Cidara Therapeutics Stock (CDTX)

What analysts predicted

Upside of 22.26%

Target:

$61.80

Current:

$50.55

Insights on Cidara Therapeutics Stock (Ticker Symbol: CDTX)

  • Price Movement

    In the last 1 month, CDTX stock has moved up by 99.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 17.58M → 302.0K (in $), with an average decrease of 74.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -52.30M → -23.48M (in $), with an average increase of 122.8% per quarter

Cidara Therapeutics Technicals Summary

Sell

Neutral

Buy

Cidara Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cidara Therapeutics (CDTX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cidara Therapeutics Inc logo
99.01%
103.01%
338.26%
243.33%
-32.65%
Regeneron Pharmaceuticals, Inc. logo
5.83%
-25.33%
-48.03%
-10.86%
-11.77%
Beone Medicines Ltd logo
-7.31%
37.46%
69.18%
38.13%
24.73%
Vertex Pharmaceuticals Incorporated logo
4.51%
13.14%
-4.06%
58.55%
58.35%
Alnylam Pharmaceuticals, Inc. logo
4.34%
31.87%
24.52%
110.19%
95.5%

About Cidara Therapeutics

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
Organization
Cidara Therapeutics
Employees
38
CEO
Dr. Jeffrey L. Stein Ph.D.
Industry
Health Technology

Management People of Cidara Therapeutics

NameTitle
Dr. Jeffrey L. Stein Ph.D.
President, CEO & Executive Director
Dr. Leslie Tari Ph.D.
Chief Scientific Officer
Dr. Kevin M. Forrest Ph.D.
Founder & Chief Strategy Officer
Mr. Frank L. Karbe M.B.A.
Chief Financial Officer
Mr. Shane M. Ward J.D.
COO & Corporate Secretary
Dr. Preetam Shah M.B.A., Ph.D.
Principal Accounting Officer
Ms. Allison Lewis CCP, SPHR
Senior Vice President of People & Culture
Dr. Nicole Davarpanah J.D., M.D.
Chief Medical Officer
Mr. Jim Beitel M.B.A.
Chief Business Officer
Ms. Corrina Pavetto
Senior Vice President of Clinical Development

Important FAQs about investing in CDTX Stock from India :

Can Indians buy Cidara Therapeutics shares?

Yes, Indians can invest in the Cidara Therapeutics (CDTX) from India.

With INDmoney, you can buy Cidara Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cidara Therapeutics at zero transaction cost.

How can I buy Cidara Therapeutics shares from India?

It is very easy to buy Cidara Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cidara Therapeutics (CDTX) be purchased?

Yes, you can buy fractional shares of Cidara Therapeutics with INDmoney app.

What are the documents required to start investing in Cidara Therapeutics stocks?

To start investing in Cidara Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Cidara Therapeutics share price today?

Cidara Therapeutics share price today stands at $50.55, Open: $47.99 ; Previous Close: $48.30 ; High: $50.59 ; Low: $46.01 ; 52 Week High: $56.83 ; 52 Week Low: $10.14.

The stock opens at $47.99, after a closing price of $48.30. The stock reached a daily high of $50.59 and a low of $46.01, with a 52-week high of $56.83 and a 52-week low of $10.14.

What are today’s High and Low prices of Cidara Therapeutics Stock (CDTX)?

Today’s highest price of Cidara Therapeutics (CDTX) is $50.59.

Today’s lowest price of Cidara Therapeutics (CDTX) is $46.01.

What is the 52 Week High and Low Range of Cidara Therapeutics Stock (CDTX)?

  • 52 Week High

    $56.83

  • 52 Week Low

    $10.14

What are the historical returns of Cidara Therapeutics (CDTX)?

  • 1 Month Returns

    99.01%

  • 3 Months Returns

    103.01%

  • 1 Year Returns

    338.26%

  • 5 Years Returns

    -32.65%

What is today's market capitalisation of Cidara Therapeutics?

Today's market capitalisation of Cidara Therapeutics CDTX is 1.0B

Who is the Chief Executive Officer (CEO) of Cidara Therapeutics ?

Dr. Jeffrey L. Stein Ph.D. is the current Chief Executive Officer (CEO) of Cidara Therapeutics.